Choosing a health software development partner
Assess a health software partner through workflow evidence, privacy controls, relevant conformance, regulatory scope and responsibilities after release.
Choose a health software development partner on evidence of how they handle the complete service: the clinical workflow, sensitive information, external connections, testing and support. A feature demonstration cannot answer all of those questions.
Begin with your product's intended purpose and the people who will use it. That establishes which obligations and integrations need investigation before either party commits to a detailed delivery plan.
Ask for evidence against the proposed work
A relevant example should identify the product, the partner's role, the delivered scope and the status reached. A prototype, an integration test and a production release are different forms of evidence. Each can be useful when it is described accurately.
| Area | Evidence to request |
|---|---|
| Workflow | A complete scenario showing preparation, review, authority and exception handling |
| Information | A map of collection, storage, access, sharing and retention |
| External services | Named integrations, applicable requirements and tested product versions |
| Quality | Acceptance criteria, representative tests and unresolved release dependencies |
| Operations | Support ownership, incident arrangements and credential maintenance |
| Continuity | Documentation, source access, recovery arrangements and an exit process |
Ask the proposed delivery team to explain an incomplete or failed scenario. Their response will often tell you more than another successful demonstration.
Establish privacy and access responsibilities
The OAIC's health privacy guidance explains that health information receives particular protection under the Privacy Act. Confirm how that framework applies to your organisation and product, alongside any relevant state or territory requirements.
Ask who can access production information, from where and for what purpose. Include support staff, administrators and subcontractors. Australian hosting alone does not answer those questions.
Set rules for development and test data before records are copied. Use synthetic or appropriately de-identified information where it can support the test. Where real information is necessary, agree access, protection and disposal controls for every environment.
Check the scope of regulatory claims
An organisation-wide statement that a vendor is “ADHA approved” is too broad to assess. Ask which product, version, service and conformance profile the evidence covers, then check the relevant official record.
Software's TGA regulatory position also needs to be assessed for its intended purpose and applicable exclusions or exemptions. Not every application used in healthcare is regulated in the same way. Record the assessment and revisit it when the product's purpose changes.
Keep responsibility clear. The client and its advisers confirm the applicable legal, clinical and regulatory obligations. The development team needs to translate agreed requirements into product behaviour, tests and evidence. Neither side should leave that translation to an assumption in a proposal.
Walk through an incident before signing
Ask how the team would investigate an unexpected disclosure, incorrect record change or unavailable external service. Establish who contains the issue, preserves evidence, contacts the client and authorises recovery. Confirm notification duties with the organisation's privacy and legal advisers.
Request evidence of access control, patching, backup recovery and the removal of access when people leave. A policy is useful, but a demonstrated control gives the buyer a firmer basis for judging the proposed service.
Distinguish delivery proof from a promise
Twin Global developed ScriptStream for BOP Plus, including workflow engineering, Australian health-system integrations and conformance support. The product is in early production, with onboarding and further development continuing. Full PRODA integration remains in progress.
Use that level of specificity when assessing any partner. Ask what has been delivered, what remains open and who owns the next decision. Those answers are more useful than a broad assurance that the team understands healthcare.